Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.

Chief Financial Officer

Tim Watts

Tim joined the company as Interim Chief Financial Officer in August 2018 and brings with him over 25 years’ experience in the pharmaceutical and biotech sectors. A qualified chartered accountant, Tim joined ICI in 1985 and moved into ICI Pharmaceuticals (which became Zeneca Pharmaceuticals before merging with Astra to form AstraZeneca PLC) in 1990. Tim was appointed Finance Director of the Zeneca Pharmaceuticals business in 1998 and became Group Financial Controller of AstraZeneca plc in 2002. Between 2007 and 2011 Tim was CFO of Archimedes Pharma and CFO of Oxford Biomedica plc from 2012 until September 2017. Tim is a non-executive director of Fusion Antibodies plc and also works in an advisory capacity with several small start-up companies.

Back to team